Cargando…
Diet was less significant than physical activity in the prognosis of people with sarcopenia and metabolic dysfunction-associated fatty liver diseases: Analysis of the National Health and Nutrition Examination Survey III
BACKGROUND: Sarcopenia is prevalent in metabolic dysfunction-associated fatty liver diseases (MAFLD), and the primary treatment for both diseases is lifestyle modification. We studied how dietary components and physical activity affect individuals with sarcopenia and MAFLD. MATERIALS AND METHODS: We...
Autores principales: | Yi, Yun, Wang, Chun, Ding, Yang, He, JiangHua, Lv, YuQing, Chang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995978/ https://www.ncbi.nlm.nih.gov/pubmed/36909338 http://dx.doi.org/10.3389/fendo.2023.1101892 |
Ejemplares similares
-
Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023) -
Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VII
por: Song, Eyun, et al.
Publicado: (2021) -
Signatures and Clinical Significance of Amino Acid Flux in Sarcopenia: A Systematic Review and Meta-Analysis
por: Dai, Miao, et al.
Publicado: (2021) -
Eating for 3.8 × 10(13): Examining the Impact of Diet and Nutrition on the Microbiota-Gut-Brain Axis Through the Lens of Microbial Endocrinology
por: Lyte, Joshua M.
Publicado: (2019) -
The role of obesity in sarcopenia and the optimal body composition to prevent against sarcopenia and obesity
por: Liu, Chaoran, et al.
Publicado: (2023)